Shingrix Vaccine

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

Shingrix Vaccine is a recombinant, adjuvanted herpes zoster vaccine. Its labelling describes it for the prevention of shingles (herpes zoster) and its complication post-herpetic neuralgia, and it is recommended for adults aged 50 years and older. It is given by a healthcare professional into the upper-arm muscle as two doses, with a gap of at least about two to six months between doses.

Active ingredient
Varicella zoster virus glycoprotein E antigen with AS01B adjuvant system
Dosage form
Powder and suspension for suspension for intramuscular injection
Therapeutic class
Recombinant adjuvanted viral vaccine (active immunisation)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with the recombinant adjuvanted herpes zoster vaccine and this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Described for the prevention of shingles (herpes zoster)
  • Described for the prevention of post-herpetic neuralgia, the persistent nerve pain that can follow shingles
  • Described as recommended for adults aged 50 years and older
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Administered only by a doctor into the upper-arm muscle — not self-administered
  • Given as two doses, with both doses taken on time for maximum benefit
  • The interval between doses set by the healthcare provider should be followed

Described Side Effects

Commonly described side effects include:

  • Injection-site reactions (pain, swelling, redness)
  • Muscle pain
  • Tiredness (fatigue)
  • Headache
  • Shivering
  • Fever
  • Gastrointestinal symptoms

These are described as usually short-lived. Any severe, persistent, or unexpected reaction requires prompt medical attention.

Precautions

  • A complete medical history and any allergies should be shared with the doctor
  • The doctor should be told about any infection with a high fever, so administration can be timed appropriately
  • The doctor should be told about any bleeding problems or a tendency to bruise easily
  • Pregnant or breastfeeding women should consult their doctor beforehand

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it is a recombinant, adjuvanted herpes zoster vaccine used to help prevent shingles and post-herpetic neuralgia in adults aged 50 years and older. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling states it is administered by a doctor into the upper-arm muscle as two doses, with the interval set by the healthcare provider. Both doses should be taken on time.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services